A comparative study assessing the efficacy and acceptability of anorectal swabs for antenatal Group B Streptococcus (GBS) screening

Not Applicable

Completed

• Conditions: Group B Streptococcal (GBS) colonisation in pregnant women; Reproductive Health and Childbirth - Antenatal care; Infection - Studies of infection and infectious agents

• Registration Number: ACTRN12611000863932
• Lead Sponsor: ambour General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Pregnant women at 35-37 weeks gestation
Planning vaginal delivery

Exclusion Criteria

Planning elective Caesarean delivery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score for collection of the swabs, on a 5 point Likert scale (Pain-free, Minor discomfort, Moderate pain, Very painful, Unbearable)[At the time of collecting the swabs]

Secondary Outcome Measures

Name	Time	Method
Acceptability for collection of the swabs, on a 5 point Likert scale (Totally acceptable, Somewhat acceptable, Acceptable, Not acceptable, Not at all acceptable)[At the time of collecting the swabs];Positivity rate of the LVS and ARS for GBS. The swabs are analysed by microbiological culture in an approved and accredited microbiological laboratory, and the results are reported electronically as either positive or negative for GBS.[At the time of collecting the swabs]